Reduction_NN
of_IN
tumor_NN
necrosis_NN
factor_NN
alpha_NN
expression_NN
and_CC
signalling_NN
in_IN
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
from_IN
patients_NNS
with_IN
thalassemia_NN
or_CC
sickle_JJ
cell_NN
anemia_NN
upon_IN
treatment_NN
with_IN
desferrioxamine_NN
._.

Recent_JJ
evidence_NN
indicates_VBZ
that_IN
the_DT
rate_NN
of_IN
progression_NN
of_IN
the_DT
HIV-1_NN
disease_NN
is_VBZ
significantly_RB
reduced_VBN
in_IN
thalassemia_NN
major_JJ
patients_NNS
upon_IN
treatment_NN
with_IN
high_JJ
doses_NNS
of_IN
desferrioxamine_NN
-LRB-_-LRB-
DFX_NN
-RRB-_-RRB-
._.

The_DT
authors_NNS
have_VBP
previously_RB
demonstrated_VBN
that_IN
in_FW
vitro_FW
exposure_NN
of_IN
mononuclear_JJ
cells_NNS
to_TO
DFX_NN
decreases_VBZ
the_DT
bioavailability_NN
of_IN
tumor_NN
necrosis_NN
factor_NN
alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
which_WDT
has_VBZ
a_DT
stimulatory_JJ
effect_NN
on_IN
HIV-1_NN
replication_NN
._.

In_IN
this_DT
study_NN
,_,
therefore_RB
,_,
TNF-alpha_NN
bioavailability_NN
from_IN
mononuclear_JJ
cells_NNS
isolated_VBN
from_IN
10_CD
patients_NNS
with_IN
thalassemia_NN
or_CC
sickle_JJ
cell_NN
anemia_NN
given_JJ
DFX_NN
as_RB
compared_VBN
to_TO
10_CD
untreated_JJ
subjects_NNS
has_VBZ
been_VBN
evaluated_VBN
._.

Evidence_NN
is_VBZ
presented_VBN
showing_VBG
that_IN
DFX_NN
treatment_NN
reduces_VBZ
TNF-alpha_NN
bioavailability_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.05_CD
-RRB-_-RRB-
by_IN
inhibiting_VBG
its_PRP$
steady_JJ
state_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.05_CD
-RRB-_-RRB-
and_CC
by_IN
enhancing_VBG
its_PRP$
inactivation_NN
through_IN
binding_NN
to_TO
soluble_JJ
TNF-alpha_NN
receptor_NN
type_NN
II_CD
-LRB-_-LRB-
P_NN
&lt;_JJR
0.05_CD
-RRB-_-RRB-
._.

We_PRP
also_RB
show_VBP
that_IN
DFX_NN
treatment_NN
limits_VBZ
the_DT
in_FW
vivo_FW
activation_NN
of_IN
NF-kappaB_NN
,_,
a_DT
transcription_NN
factor_NN
involved_VBN
in_IN
both_CC
TNF-alpha_NN
gene_NN
transcription_NN
and_CC
TNF-alpha_NN
signalling_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.005_CD
-RRB-_-RRB-
._.

We_PRP
conclude_VBP
that_IN
TNF-alpha_NN
bioavailability_NN
and_CC
signalling_NN
are_VBP
impaired_JJ
in_IN
patients_NNS
upon_IN
DFX_NN
treatment_NN
._.

This_DT
mechanism_NN
may_MD
contribute_VB
to_TO
delayed_VBN
progression_NN
of_IN
the_DT
HIV-1_NN
infection_NN
in_FW
vivo_FW
._.

Copyright_NN
1999_CD
Academic_NNP
Press_NNP
._.

